Alkermes (ALKS) Net Equity Issued and Repurchased (2014)
Alkermes' (ALKS) quarterly Net Equity Issued and Repurchased came in at $248.4 million in Q1 2014.
Powered by 
Analysis
Alkermes (ALKS) Net Equity Issued and Repurchased (2014) Analysis & Trends
Alkermes (ALKS) has reported Net Equity Issued and Repurchased for 1 consecutive years, with $248.4 million the latest figure, recorded in Q1 2014.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $248.4 million in Q1 2014; TTM through Dec 2014 was $248.4 million, a N/A change from a year earlier, with the FY2014 full-year figure at $248.4 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased was $248.4 million for Q1 2014 at Alkermes.
- Over five years, Net Equity Issued and Repurchased peaked at $248.4 million in Q1 2014 and troughed at $248.4 million in Q1 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 141.90 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Alkermes | 7.58 Bn | 6.92 Bn | 397.90 Mn | - |